Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Altamira Therapeutics Ltd
CYTO
Healthcare
Altamira Therapeutics Ltd. is a Bermuda-based company engaged in developing ribonucleic acid (RNA)-based therapeutics for extrahepatic targets (OligoPhore/SemaPhore delivery platforms). The Company has two flagship short interfering (siRNA) programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. The delivery...
platform is also suited for messenger RNA (mRNA) and other types of RNA therapeutics and is focused to be leveraged via out-licensing to pharma or biotech companies. The therapeutic objective for AM-401 is to slow down KRAS driven tumor cell growth and proliferation or to stop it altogether by delivering siRNA specifically inside tumor cells for gene knock down. AM-411 is a polyplex nanoparticle delivering siRNA to inflamed tissues to target the NF-kB signaling pathway, a critical regulator of immune and inflammatory responses. Like AM-401, the drug product is based on its OligoPhore technology.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:CYTO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
Next
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 12:54pm
CYTO .... I just take what the market gives
Short covered .... Thx !!!
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 12:51pm
CYTO...... nice
Drop u pig !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 12:48pm
CYTO .... short position set up
$3.25
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 11:54am
CYTO ..... Thx for the scalp ; )
No position
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 11:51am
CYTO....... Thx for the cheap stuff
Bot the dip to support ; )
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 11:19am
CYTO..... still no position
Broke support...... I don't like this anymore...next support is $3.07 Just watching
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 11:04am
CYTO .... start the drumroll
Cheers
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 10:45am
CYTO..... watching for volume spike
Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 10:43am
CYTO....possible bounce off the $3.47
No position
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 9:56am
CYTO...... U ask why I feel the sh price is going higher
Try liking my posts ya bunch of mooches ....then I'll be more specific Grass ....gas or a$$ Nobody rides for free ; )
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 9:43am
CYTO ..... I tend to think that........
The share price will go higher I would be more specific however.....money is money.... I always like to leave some for the next guy ; ) Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 9:40am
CYTO ..... Sold to America
Now that's a big Cha - Ching !!!!!
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 8:57am
CYTO..... Kabooom !!!!!!!!!!!
Clinical Study Demonstrates Bentrio's Superior Nasal Residence Time and Rheological Properties 2023-03-03 05:47 ET - News Release Bentrio® remained
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 03, 2023 8:47am
New Press Release - Clinical Study Demonstrates Bentrio's Superior Nasal Residence Time and Rheological Properties
Bentrio® remained detectable by fluorescence for up to 210 minutes in subjects' nasal passages vs. 60 minutes with saline nasal spray controlLong nasal residence time supports extended protective effects against airborne allergens and other potentially harmful particlesHAMILTON, BERMUDA...
read article.
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 01, 2023 1:48pm
CYTO ..... Ammendment to Registration Statement form F-1/A
Now I want you to read every word............. https://www.sec.gov/ix?doc=/Archives/edgar/data/1601936/000121390023016044/ea174488-f1a2_altamira.htm
Prev
1
2
3
4
5
6
7
8
9
10
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share